{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:12:39Z","timestamp":1794543159282,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171131"],"award-info":[{"award-number":["32171131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32371181"],"award-info":[{"award-number":["32371181"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071429"],"award-info":[{"award-number":["82071429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["2021ZDSYS11"],"award-info":[{"award-number":["2021ZDSYS11"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2022MC098"],"award-info":[{"award-number":["ZR2022MC098"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Taishan Scholars Construction Project","award":["tsqn202408166"],"award-info":[{"award-number":["tsqn202408166"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-025-03455-x","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T21:45:07Z","timestamp":1745963107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Repurposing of epalrestat for neuroprotection in parkinson\u2019s disease via activation of the KEAP1\/Nrf2 pathway"],"prefix":"10.1186","volume":"22","author":[{"given":"Huafang","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyue","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"3455_CR1","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/mds.25844","volume":"29","author":"D Berg","year":"2014","unstructured":"Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson\u2019s disease. Mov Disord. 2014;29:454\u201362.","journal-title":"Mov Disord"},{"key":"3455_CR2","volume":"46","author":"T Xu","year":"2024","unstructured":"Xu T, Dong W, Liu J, Yin P, Wang Z, Zhang L, Zhou M. Disease burden of Parkinson\u2019s disease in China and its provinces from 1990 to 2021: findings from the global burden of disease study 2021. Lancet Reg Health West Pac. 2024;46: 101078.","journal-title":"Lancet Reg Health West Pac"},{"key":"3455_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","volume":"15","author":"A Elkouzi","year":"2019","unstructured":"Elkouzi A, Vedam-Mai V, Eisinger RS, Okun MS. Emerging therapies in Parkinson disease - repurposed drugs and new approaches. Nat Rev Neurol. 2019;15:204\u201323.","journal-title":"Nat Rev Neurol"},{"key":"3455_CR4","doi-asserted-by":"publisher","first-page":"6052","DOI":"10.1080\/07391102.2021.1875878","volume":"40","author":"S Choudhary","year":"2022","unstructured":"Choudhary S, Silakari O. Virtual screening of epalrestat mimicking selective ALR2 inhibitors from natural product database: auto pharmacophore, ADMET prediction and molecular dynamics approach. J Biomol Struct Dyn. 2022;40:6052\u201370.","journal-title":"J Biomol Struct Dyn"},{"key":"3455_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41401-018-0043-5","volume":"40","author":"J He","year":"2019","unstructured":"He J, Gao HX, Yang N, Zhu XD, Sun RB, Xie Y, Zeng CH, Zhang JW, Wang JK, Ding F, et al. The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db\/db mice through metabolic modulation. Acta Pharmacol Sin. 2019;40:86\u201397.","journal-title":"Acta Pharmacol Sin"},{"key":"3455_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1592\/phco.28.5.646","volume":"28","author":"MA Ramirez","year":"2008","unstructured":"Ramirez MA, Borja NL. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy. Pharmacotherapy. 2008;28:646\u201355.","journal-title":"Pharmacotherapy"},{"key":"3455_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1210\/er.2004-0028","volume":"26","author":"SK Srivastava","year":"2005","unstructured":"Srivastava SK, Ramana KV, Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev. 2005;26:380\u201392.","journal-title":"Endocr Rev"},{"key":"3455_CR8","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1084\/jem.20160903","volume":"214","author":"X Wu","year":"2017","unstructured":"Wu X, Li X, Fu Q, Cao Q, Chen X, Wang M, Yu J, Long J, Yao J, Liu H, et al. AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program. J Exp Med. 2017;214:1065\u201379.","journal-title":"J Exp Med"},{"key":"3455_CR9","doi-asserted-by":"crossref","unstructured":"Zhang KR, Zhang YF, Lei HM, Tang YB, Ma CS, Lv QM, Wang SY, Lu LM, Shen Y, Chen HZ, Zhu L: Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer. Sci Transl Med 2021, 13:eabg6428.","DOI":"10.1126\/scitranslmed.abg6428"},{"key":"3455_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12974-022-02632-6","volume":"19","author":"K Zhong","year":"2022","unstructured":"Zhong K, Huang Y, Zilundu PLM, Wang Y, Zhou Y, Yu G, Fu R, Chung SK, Tang Y, Cheng X, Zhou L. Motor neuron survival is associated with reduced neuroinflammation and increased autophagy after brachial plexus avulsion injury in aldose reductase-deficient mice. J Neuroinflammation. 2022;19:271.","journal-title":"J Neuroinflammation"},{"key":"3455_CR11","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1186\/s12967-023-04380-4","volume":"21","author":"W Shi","year":"2023","unstructured":"Shi W, Xu G, Gao Y, Zhao J, Liu T, Zhao J, Yang H, Wei Z, Li H, Xu AL, et al. Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase. J Transl Med. 2023;21:700.","journal-title":"J Transl Med"},{"key":"3455_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.redox.2014.12.002","volume":"4","author":"K Yama","year":"2015","unstructured":"Yama K, Sato K, Abe N, Murao Y, Tatsunami R, Tampo Y. Epalrestat increases glutathione, thioredoxin, and heme oxygenase-1 by stimulating Nrf2 pathway in endothelial cells. Redox Biol. 2015;4:87\u201396.","journal-title":"Redox Biol"},{"key":"3455_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3892\/etm.2021.9824","volume":"21","author":"R Tatsunami","year":"2021","unstructured":"Tatsunami R, Sato K, Murao Y, Yama K, Yu Y, Ohno S, Tampo Y. Epalrestat suppresses cadmium-induced cytotoxicity through Nrf2 in endothelial cells. Exp Ther Med. 2021;21:393.","journal-title":"Exp Ther Med"},{"key":"3455_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2015.04.036","volume":"88","author":"AT Dinkova-Kostova","year":"2015","unstructured":"Dinkova-Kostova AT, Abramov AY. The emerging role of Nrf2 in mitochondrial function. Free Radic Biol Med. 2015;88:179\u201388.","journal-title":"Free Radic Biol Med"},{"key":"3455_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/pin.12261","volume":"65","author":"H Yamazaki","year":"2015","unstructured":"Yamazaki H, Tanji K, Wakabayashi K, Matsuura S, Itoh K. Role of the Keap1\/Nrf2 pathway in neurodegenerative diseases. Pathol Int. 2015;65:210\u20139.","journal-title":"Pathol Int"},{"key":"3455_CR16","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.bbadis.2013.12.011","volume":"1842","author":"L Gan","year":"2014","unstructured":"Gan L, Johnson JA. Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases. Biochim Biophys Acta. 2014;1842:1208\u201318.","journal-title":"Biochim Biophys Acta"},{"key":"3455_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101915","volume":"87","author":"S Rajan","year":"2023","unstructured":"Rajan S, Tryphena KP, Khan S, Vora L, Srivastava S, Singh SB, Khatri DK. Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson\u2019s disease. Ageing Res Rev. 2023;87: 101915.","journal-title":"Ageing Res Rev"},{"key":"3455_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon DK, Tanner CM, Brundin P. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clin Geriatr Med. 2020;36:1\u201312.","journal-title":"Clin Geriatr Med"},{"key":"3455_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s12640-020-00305-x","volume":"39","author":"Z Elmazoglu","year":"2021","unstructured":"Elmazoglu Z, Prnova MS, Santamaria A, Stefek M, Karasu C. Combatting Nitrosative Stress and Inflammation with Novel Substituted Triazinoindole Inhibitors of Aldose Reductase in PC12 Cells Exposed to 6-Hydroxydopamine Plus High Glucose. Neurotox Res. 2021;39:210\u201326.","journal-title":"Neurotox Res"},{"key":"3455_CR20","doi-asserted-by":"publisher","first-page":"867","DOI":"10.4014\/jmb.2101.01002","volume":"31","author":"S Lingappa","year":"2021","unstructured":"Lingappa S, Shivakumar MS, Manivasagam T, Somasundaram ST, Seedevi P. Neuroprotective Effect of Epalrestat on Hydrogen Peroxide-Induced Neurodegeneration in SH-SY5Y Cellular Model. J Microbiol Biotechnol. 2021;31:867\u201374.","journal-title":"J Microbiol Biotechnol"},{"key":"3455_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.neuint.2006.04.015","volume":"49","author":"H Jiang","year":"2006","unstructured":"Jiang H, Luan Z, Wang J, Xie J. Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Neurochem Int. 2006;49:605\u20139.","journal-title":"Neurochem Int"},{"key":"3455_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrn1868","volume":"7","author":"PM Abou-Sleiman","year":"2006","unstructured":"Abou-Sleiman PM, Muqit MM, Wood NW. Expanding insights of mitochondrial dysfunction in Parkinson\u2019s disease. Nat Rev Neurosci. 2006;7:207\u201319.","journal-title":"Nat Rev Neurosci"},{"key":"3455_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd1330","volume":"3","author":"KJ Barnham","year":"2004","unstructured":"Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov. 2004;3:205\u201314.","journal-title":"Nat Rev Drug Discov"},{"key":"3455_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1242\/bio.20134853","volume":"2","author":"KM Holmstrom","year":"2013","unstructured":"Holmstrom KM, Baird L, Zhang Y, Hargreaves I, Chalasani A, Land JM, Stanyer L, Yamamoto M, Dinkova-Kostova AT, Abramov AY. Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration. Biol Open. 2013;2:761\u201370.","journal-title":"Biol Open"},{"key":"3455_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cotox.2016.10.002","volume":"1","author":"KM Holmstrom","year":"2016","unstructured":"Holmstrom KM, Kostov RV, Dinkova-Kostova AT. The multifaceted role of Nrf2 in mitochondrial function. Curr Opin Toxicol. 2016;1:80\u201391.","journal-title":"Curr Opin Toxicol"},{"key":"3455_CR26","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nrd.2018.136","volume":"17","author":"D Charvin","year":"2018","unstructured":"Charvin D, Medori R, Hauser RA, Rascol O. Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs. Nat Rev Drug Discov. 2018;17:804\u201322.","journal-title":"Nat Rev Drug Discov"},{"key":"3455_CR27","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3233\/JPD-219006","volume":"11","author":"K McFarthing","year":"2021","unstructured":"McFarthing K, Rafaloff G, Baptista MAS, Wyse RK, Stott SRW. Parkinson\u2019s Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update. J Parkinsons Dis. 2021;11:891\u2013903.","journal-title":"J Parkinsons Dis"},{"key":"3455_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18:41\u201358.","journal-title":"Nat Rev Drug Discov"},{"key":"3455_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/toxsci\/kfx038","volume":"163","author":"Y Le","year":"2018","unstructured":"Le Y, Chen L, Zhang Y, Bu P, Dai G, Cheng X. Epalrestat Stimulated Oxidative Stress, Inflammation, and Fibrogenesis in Mouse Liver. Toxicol Sci. 2018;163:397\u2013408.","journal-title":"Toxicol Sci"},{"key":"3455_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s12035-013-8554-z","volume":"49","author":"G Anderson","year":"2014","unstructured":"Anderson G, Maes M. Neurodegeneration in Parkinson\u2019s disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins. Mol Neurobiol. 2014;49:771\u201383.","journal-title":"Mol Neurobiol"},{"key":"3455_CR31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2013.05.042","volume":"62","author":"R Perfeito","year":"2013","unstructured":"Perfeito R, Cunha-Oliveira T, Rego AC. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. Free Radic Biol Med. 2013;62:186\u2013201.","journal-title":"Free Radic Biol Med"},{"key":"3455_CR32","doi-asserted-by":"crossref","unstructured":"Jenner P: Oxidative stress in Parkinson's disease. Ann Neurol 2003, 53 Suppl 3:S26\u201336; discussion S36\u201328.","DOI":"10.1002\/ana.10483"},{"key":"3455_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mcn.2014.08.002","volume":"62","author":"R Perfeito","year":"2014","unstructured":"Perfeito R, Lazaro DF, Outeiro TF, Rego AC. Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells. Mol Cell Neurosci. 2014;62:51\u20139.","journal-title":"Mol Cell Neurosci"},{"key":"3455_CR34","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla LF, Song P, Mazzulli JR, Zampese E, Wong YC, Jeon S, Santos DP, Blanz J, Obermaier CD, Strojny C, et al. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science. 2017;357:1255\u201361.","journal-title":"Science"},{"key":"3455_CR35","doi-asserted-by":"publisher","first-page":"13548","DOI":"10.1038\/ncomms13548","volume":"7","author":"C Dolle","year":"2016","unstructured":"Dolle C, Flones I, Nido GS, Miletic H, Osuagwu N, Kristoffersen S, Lilleng PK, Larsen JP, Tysnes OB, Haugarvoll K, et al. Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease. Nat Commun. 2016;7:13548.","journal-title":"Nat Commun"},{"key":"3455_CR36","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ng1769","volume":"38","author":"A Bender","year":"2006","unstructured":"Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS, Betts J, Klopstock T, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet. 2006;38:515\u20137.","journal-title":"Nat Genet"},{"key":"3455_CR37","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/jnen\/61.7.634","volume":"61","author":"G Gu","year":"2002","unstructured":"Gu G, Reyes PE, Golden GT, Woltjer RL, Hulette C, Montine TJ, Zhang J. Mitochondrial DNA deletions\/rearrangements in parkinson disease and related neurodegenerative disorders. J Neuropathol Exp Neurol. 2002;61:634\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3455_CR38","doi-asserted-by":"crossref","unstructured":"Burns RS, LeWitt PA, Ebert MH, Pakkenberg H, Kopin IJ: The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med 1985, 312:1418\u20131421.","DOI":"10.1056\/NEJM198505303122203"},{"key":"3455_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1006\/exnr.1997.6752","volume":"150","author":"HM Schipper","year":"1998","unstructured":"Schipper HM, Liberman A, Stopa EG. Neural heme oxygenase-1 expression in idiopathic Parkinson\u2019s disease. Exp Neurol. 1998;150:60\u20138.","journal-title":"Exp Neurol"},{"key":"3455_CR40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.brainres.2007.01.131","volume":"1144","author":"RJ Jakel","year":"2007","unstructured":"Jakel RJ, Townsend JA, Kraft AD, Johnson JA. Nrf2-mediated protection against 6-hydroxydopamine. Brain Res. 2007;1144:192\u2013201.","journal-title":"Brain Res"},{"key":"3455_CR41","doi-asserted-by":"publisher","first-page":"17775","DOI":"10.1523\/JNEUROSCI.3049-12.2012","volume":"32","author":"L Gan","year":"2012","unstructured":"Gan L, Vargas MR, Johnson DA, Johnson JA. Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model. J Neurosci. 2012;32:17775\u201387.","journal-title":"J Neurosci"},{"key":"3455_CR42","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1073\/pnas.0813361106","volume":"106","author":"PC Chen","year":"2009","unstructured":"Chen PC, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, Johnson JA. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson\u2019s disease: Critical role for the astrocyte. Proc Natl Acad Sci U S A. 2009;106:2933\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3455_CR43","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/glia.20947","volume":"58","author":"AI Rojo","year":"2010","unstructured":"Rojo AI, Innamorato NG, Martin-Moreno AM, De Ceballos ML, Yamamoto M, Cuadrado A. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson\u2019s disease. Glia. 2010;58:588\u201398.","journal-title":"Glia"},{"key":"3455_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2019.100942","volume":"54","author":"L Fao","year":"2019","unstructured":"Fao L, Mota SI, Rego AC. Shaping the Nrf2-ARE-related pathways in Alzheimer\u2019s and Parkinson\u2019s diseases. Ageing Res Rev. 2019;54: 100942.","journal-title":"Ageing Res Rev"},{"key":"3455_CR45","doi-asserted-by":"crossref","unstructured":"Martin-Montanez E, Valverde N, Ladron de Guevara-Miranda D, Lara E, Romero-Zerbo YS, Millon C, Boraldi F, Avila-Gamiz F, Perez-Cano AM, Garrido-Gil P, et al: Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson's disease. Redox Biol 2021, 46:102095.","DOI":"10.1016\/j.redox.2021.102095"},{"key":"3455_CR46","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41467-020-14788-x","volume":"11","author":"Y Wei","year":"2020","unstructured":"Wei Y, Lu M, Mei M, Wang H, Han Z, Chen M, Yao H, Song N, Ding X, Ding J, et al. Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection. Nat Commun. 2020;11:941.","journal-title":"Nat Commun"},{"key":"3455_CR47","doi-asserted-by":"crossref","unstructured":"Guo B, Zheng C, Cao J, Luo F, Li H, Hu S, Mingyuan Lee S, Yang X, Zhang G, Zhang Z, et al: Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1alpha\/Nrf2 pathway in Parkinson's disease models. J Adv Res 2023.","DOI":"10.1016\/j.jare.2023.11.021"},{"key":"3455_CR48","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1039\/D3SC06997D","volume":"15","author":"J Yim","year":"2024","unstructured":"Yim J, Hwang YS, Lee JJ, Kim JH, Baek JY, Jeong J, Choi YI, Jin BK, Park SB. Inflachromene ameliorates Parkinson\u2019s disease by targeting Nrf2-binding Keap1. Chem Sci. 2024;15:3588\u201395.","journal-title":"Chem Sci"},{"key":"3455_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115972","volume":"170","author":"HS Lim","year":"2024","unstructured":"Lim HS, Park G. Artemisinin protects dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in a mouse model of Parkinson\u2019s disease. Biomed Pharmacother. 2024;170: 115972.","journal-title":"Biomed Pharmacother"},{"key":"3455_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.148954","volume":"1836","author":"S Shah","year":"2024","unstructured":"Shah S, Pushpa Tryphena K, Singh G, Kulkarni A, Pinjala P, Kumar Khatri D. Neuroprotective role of Carvacrol via Nrf2\/HO-1\/NLRP3 axis in Rotenone-induced PD mice model. Brain Res. 2024;1836: 148954.","journal-title":"Brain Res"},{"key":"3455_CR51","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.3233\/JAD-220793","volume":"94","author":"SM Shirgadwar","year":"2023","unstructured":"Shirgadwar SM, Kumar R, Preeti K, Khatri DK, Singh SB. Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson\u2019s Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk. J Alzheimers Dis. 2023;94:S109\u201324.","journal-title":"J Alzheimers Dis"},{"key":"3455_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148462","volume":"1815","author":"M Khot","year":"2023","unstructured":"Khot M, Sood A, Tryphena KP, Pinjala P, Srivastava S, Singh SB, Khatri DK. Dimethyl fumarate ameliorates parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2\/Cathepsin D axis. Brain Res. 2023;1815: 148462.","journal-title":"Brain Res"},{"key":"3455_CR53","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3233\/ADR-230128","volume":"8","author":"P Pinjala","year":"2024","unstructured":"Pinjala P, Tryphena KP, Kulkarni A, Goswami PG, Khatri DK. Dimethyl Fumarate Exerts a Neuroprotective Effect by Enhancing Mitophagy via the NRF2\/BNIP3\/PINK1 Axis in the MPP(+) Iodide-Induced Parkinson\u2019s Disease Mice Model. J Alzheimers Dis Rep. 2024;8:329\u201344.","journal-title":"J Alzheimers Dis Rep"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03455-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03455-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03455-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T10:02:56Z","timestamp":1746007376000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-025-03455-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3455"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03455-x","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed following international guidelines and conducted in accordance with the Animal Ethics Committee of Qingdao University (QDU-AEC-2024766).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}